PL2288618T3 - Chimeric fusion proteins and virus like particles from birnavirus vp2 - Google Patents

Chimeric fusion proteins and virus like particles from birnavirus vp2

Info

Publication number
PL2288618T3
PL2288618T3 PL08749431T PL08749431T PL2288618T3 PL 2288618 T3 PL2288618 T3 PL 2288618T3 PL 08749431 T PL08749431 T PL 08749431T PL 08749431 T PL08749431 T PL 08749431T PL 2288618 T3 PL2288618 T3 PL 2288618T3
Authority
PL
Poland
Prior art keywords
birnavirus
virus
particles
fusion proteins
chimeric fusion
Prior art date
Application number
PL08749431T
Other languages
Polish (pl)
Inventor
Thomas Zürcher
Juan José Bernal
Kobbe Cayetano Von
Torres Ignacio Jiménez
Blázquez Ana Diaz
Lorenzo Diana Martin
Lucas Gloria Calderita
De Castro Arcadio Garcia
Original Assignee
Chimera Pharma S.L.U.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chimera Pharma S.L.U. filed Critical Chimera Pharma S.L.U.
Publication of PL2288618T3 publication Critical patent/PL2288618T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL08749431T 2008-05-09 2008-05-09 Chimeric fusion proteins and virus like particles from birnavirus vp2 PL2288618T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08749431.6A EP2288618B1 (en) 2008-05-09 2008-05-09 Chimeric fusion proteins and virus like particles from birnavirus vp2
PCT/EP2008/003778 WO2009135518A1 (en) 2008-05-09 2008-05-09 Chimeric fusion proteins and virus like particles from birnavirus vp2

Publications (1)

Publication Number Publication Date
PL2288618T3 true PL2288618T3 (en) 2018-02-28

Family

ID=40260679

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08749431T PL2288618T3 (en) 2008-05-09 2008-05-09 Chimeric fusion proteins and virus like particles from birnavirus vp2

Country Status (6)

Country Link
US (1) US8784827B2 (en)
EP (1) EP2288618B1 (en)
DK (1) DK2288618T3 (en)
ES (1) ES2659586T3 (en)
PL (1) PL2288618T3 (en)
WO (1) WO2009135518A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009135518A1 (en) * 2008-05-09 2009-11-12 Chimera Pharma S.L.U. Chimeric fusion proteins and virus like particles from birnavirus vp2
CA2779645A1 (en) 2009-11-06 2011-05-12 Chimera Pharma, S.L.U. Vaccines for the treatment of neoplasias based on viral capsids of birnavirus containing human papillomavirus antigens
WO2011054995A2 (en) * 2009-11-06 2011-05-12 Chimera Pharma, S. L. U. PROPHYLACTIC FLU VACCINES FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING THE M2e ANTIGEN OF THE FLU VIRUS
WO2013059168A2 (en) * 2011-10-21 2013-04-25 Research Development Foundation Espirito santo virus and methods for detecting and preventing infection with the same
US9732144B2 (en) 2012-07-05 2017-08-15 Ohio State Innovation Foundation Infectious bursal disease (IBDV) vaccine compositions
US10086062B2 (en) 2012-07-05 2018-10-02 Ohio State Innovation Foundation Infectious pancreatic necrosis virus (IPNV) vaccine compositions
WO2015101666A1 (en) * 2014-01-03 2015-07-09 Fundación Biofísica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
CN105255930A (en) * 2015-10-16 2016-01-20 天津瑞普生物技术股份有限公司 Preparation method of chick IBDV (infectious bursal disease virus) composite subunit vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
FR2824327B1 (en) 2001-05-02 2003-07-11 Agronomique Inst Nat Rech PSEUDOVIRAL PARTICLES OF BIRNAVIRUS
ES2307345B1 (en) 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas CHEMICAL EMPTY CAPSIDES OF THE VIRUS CAUSING THE INFECTIOUS BURSITIS DISEASE (IBDV), ITS PROCEDURE FOR OBTAINING AND APPLICATIONS.
ES2310062B1 (en) 2005-07-15 2009-11-13 Bionostra, S.L. PSEUDOVIRAL PARTICLES CHEMICAL EMPTY DERIVED FROM VIRUS CAUSING INFECTIOUS BURSITIS DISEASE (IBDV), PROCEDURE OF OBTAINING AND APPLICATIONS.
WO2009135518A1 (en) * 2008-05-09 2009-11-12 Chimera Pharma S.L.U. Chimeric fusion proteins and virus like particles from birnavirus vp2

Also Published As

Publication number Publication date
EP2288618B1 (en) 2017-09-20
DK2288618T3 (en) 2018-01-08
US8784827B2 (en) 2014-07-22
US20110190164A1 (en) 2011-08-04
ES2659586T3 (en) 2018-03-16
EP2288618A1 (en) 2011-03-02
WO2009135518A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
IL293220B1 (en) Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
PL2288618T3 (en) Chimeric fusion proteins and virus like particles from birnavirus vp2
IL218296A0 (en) Obpgplys/endolysin polypeptides, fusion proteins and compositions compriisng the same and uses thereof
EP2062246A4 (en) Chimeric virus vaccines
EP2413969A4 (en) Fusion proteins comprising canine fc portions
EP2044224A4 (en) Chimeric virus-like particles
IL207161A0 (en) Methods and compositions using klotho-fgf fusion polypeptides
EP2035565A4 (en) Methods of enhancing protein incorporation into virus like particles
IL209091A (en) Lysosomal targeted fusion proteins and uses thereof
EP2173377A4 (en) Antibody-endostatin fusion protein and its variants
GB2451014B (en) Engineered Listeria comprising a modified ActA-antigen fusion protein and its use as a vaccine
IL217121A0 (en) Antimicrobial fusion proteins and uses thereof
EP2396343A4 (en) Modified virus vectors and methods of making and using the same
EP2044198A4 (en) Chimeric influenza virus-like particles
PL2007884T3 (en) Cellulase fusion proteins and their use
HK1144440A1 (en) Hepatitis c virus antibodies
IL212040A0 (en) Hepatitis c antibodies and uses thereof
IL203221A (en) Bioactive peptides and antibodies
PL2144924T3 (en) Fusion protein vaccine
ZA201007130B (en) Fused ceramic particle
HK1152932A1 (en) Fused ring compounds and use thereof
EP2170380A4 (en) Capsid proteins and uses therefore
PL2285952T3 (en) Novel fusion proteins and use thereof for preparing hepatitis c vaccines
IL213318A0 (en) C1orf59 peptides and vaccines including the same
EP2121726A4 (en) Protein particles